Joy Anderson Reflects on Her Diagnosis of a Rare Blood Cancer

April 23rd 2025, 7:00pm

By Joy Anderson

A push for answers led to a rare blood disorder diagnosis after Joy’s symptoms were initially dismissed.

The Burst of Spring: Reflection for Those Living with Cancer

April 23rd 2025, 5:00pm

By Linda Cohen

As spring arrives, I embrace the season’s renewal, reflecting on my journey with cancer and the freedom I’ll feel when I stop my treatment. Life is a gift.

Ivonescimab Plus Chemo May Slow Advanced NSCLC Progression

April 23rd 2025, 4:00pm

By Alex Biese

In patients with advanced squamous non–small cell lung cancer, ivonescimab plus chemo was associated with progression-free survival results.

FDA Grants Breakthrough Status to CAR-T Therapy for Pediatric Brain Tumor

April 23rd 2025, 2:59pm

By Ryan Scott

The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma.

First Patient Dosed with AP402 in a Trial for HER2 Advanced Tumors

April 23rd 2025, 1:00pm

By Spencer Feldman

Advocacy and ‘Radiating Valor’ Have a Transformative Impact

April 22nd 2025, 9:00pm

By Erin Longstreth, M.S.N., RN, OCN, NEA-BC

Odronextamab Elicits Responses in Some With Lymphoma Following CAR-T

April 22nd 2025, 8:00pm

By Dr. Matthew Matasar

Overcoming Barriers to Emotional and Physical Support in Cancer Care

April 22nd 2025, 7:00pm

By Anne M. Reb

An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer progression.

Remission is Not a Cure for Follicular Lymphoma, or Any Cancer

April 22nd 2025, 4:54pm

By Karen Cohn

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

First Patient with CD5-Positive T-Cell Lymphoma Dosed with MB-105

April 22nd 2025, 4:14pm

By Alex Biese

The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

Oncodetect Test Aims to Detect Recurrence Risk Across Solid Tumors

April 22nd 2025, 3:21pm

By Spencer Feldman

The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence risk and treatment decisions.

Imfinzi Combination Shows Efficacy in Bladder Cancer Treatment

April 22nd 2025, 1:00pm

By Ryan Scott

Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder cancer, based on the NIAGARA trial.

Aspiring to Make a Difference for Immigrants

April 21st 2025, 9:00pm

By Carey Ramirez, ANP-C, ACHPN

“Don’t aspire to make a living. Let’s aspire to make a difference in the Mandarin/Cantonese-speaking community.”

Raising Awareness for Adolescents and Young Adults with Cancer

April 21st 2025, 8:00pm

By Carly Stafford Dixon

Carly Stafford Dixon, a rare cancer survivor, highlights the need for AYA cancer awareness to improve support, visibility and access to vital resources.

Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers

April 21st 2025, 7:00pm

By Spencer Feldman

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian.